| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$10 |
Way2VAT 1H24 results notification and investor webinar
|
26 Aug 2024 9:21AM |
$0.011 |
$0.007 |
fallen by
36.36%
|
|
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$669 |
Preliminary Final Report
|
26 Aug 2024 9:21AM |
$1.640 |
$2.880 |
risen by
75.61%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 25.0% from 2023 to 2024
- Profit from ordinary activities after tax attributable to owners increased by 57.1%
- FY24 Interim Dividend paid was 2.5 cents, and FY24 Final Dividend declared was 4.0 cents
- Tasmea Limited acquired Groundbreaking Mining Solutions Pty Ltd on 1 July 2023
- Tasmea Limited acquired ForeFront Services on 1 October 2023
- Tasmea Limited's subsidiary acquired Dingo Concrete Services on 1 June 2024
- Net tangible assets per ordinary security increased significantly from 5.68 cents to 19.27 cents
- The acquisitions aim to diversify client base and geographical scope of operations
- The Company's Annual General Meeting is scheduled for 19 November 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resources & Energy Group Limited (REZ) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - REZ
|
26 Aug 2024 9:20AM |
$0.027 |
$0.018 |
fallen by
33.33%
|
|
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$43 |
FY24 Full Year Profit Results
|
26 Aug 2024 9:19AM |
$0.115 |
$0.100 |
fallen by
13.04%
|
|
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$669 |
Acquisition of Future Engineering Group - Presentation
|
26 Aug 2024 9:19AM |
$1.640 |
$2.880 |
risen by
75.61%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasmea Limited to acquire 100% of Future Engineering & Communication Group (FEG) and associated entities for A$84.5 million.
- The acquisition includes A$52.5 million upfront consideration and A$17.5 million in Tasmea shares.
- 37.7% of NPAT generated by FEG for FY2025, FY2026, and FY2027 will be paid as an uncapped cash earn-out payment.
- The acquisition is expected to be earnings accretive at approximately 21%.
- The acquisition leverages the growing electrification demand in Australia.
- Significant revenue synergistic benefits are expected with existing Tasmea subsidiaries.
- The acquisition to be funded from existing cash reserves, Tasmea equity, and a new A$50 million debt acquisition facility.
- The acquisition is expected to settle on 30 August 2024.
- FEG specializes in the design, supply, and installation of communication structures and high voltage powerline infrastructure.
- FEG has a geographically diverse revenue and customer portfolio with a workforce of ~140 professionals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$43 |
FY24 Appendix 4G and Corporate Governance Statement
|
26 Aug 2024 9:19AM |
$0.115 |
$0.100 |
fallen by
13.04%
|
|
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$43 |
FY24 Appendix 4E and Annual Report
|
26 Aug 2024 9:18AM |
$0.115 |
$0.100 |
fallen by
13.04%
|
|
IDT - Price-sensitive ASX Announcement
Full Release
Key Points
- IDT Australia Limited recorded a 101% increase in revenue for FY24, reaching $14.1 million.
- Revenue growth was mainly driven by the Active Pharmaceutical Ingredients (API), Specialty Orals (SO), and Advanced Therapies (AT) business segments.
- The company raised $7 million through a non-renounceable rights issue in July 2024.
- IDT incurred a loss of $5.4 million for the year ended 30 June 2024, an improvement from the $8.5 million loss in the previous year.
- No dividends were declared or paid during FY24.
- The company's net assets stood at $23.4 million as of 30 June 2024.
- Significant investments were made in expanding the sales and marketing team, as well as direct manufacturing staff.
- The company’s cash balance at the end of the financial year was $0.5 million, bolstered by the $7 million capital raise.
- Directors believe the company will continue as a going concern due to improved revenue and recent funding activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$669 |
Acquisition of Future Engineering Group - Announcement
|
26 Aug 2024 9:18AM |
$1.640 |
$2.880 |
risen by
75.61%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasmea Limited is acquiring 100% of Future Engineering Group.
- Future Engineering Group includes Future Engineering & Communication Unit Trust, Future Power Pty Ltd, Rollwell Pty Ltd, and Westplant Pty Ltd.
- The acquisition will be completed on or about 30 August 2024.
- The acquisition price includes a cash payment of A$52.5 million, A$17.5 million in Tasmea shares, and 37.7% of NPAT generated by FEG for FY2025, FY2026, and FY2027.
- The acquisition is expected to deliver approximately 21% EPS accretion.
- FEG's key management will remain with the company under long-term agreements.
- Tasmea aims to benefit from electrification trends and growth opportunities through this acquisition.
- The acquisition aligns with Tasmea's strategy to support Australia's energy transition and expand its specialist trade skill services.
- The synergies expected from the acquisition include enhanced capabilities and new revenue streams across Tasmea's subsidiaries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IXUP Limited (IXU) ORDINARY FULLY PAID |
Information Technology |
- |
Trading Halt
|
26 Aug 2024 9:16AM |
$0.029 |
$0.009 |
fallen by
68.97%
|
|
IXU - Price-sensitive ASX Announcement
Full Release
Key Points
- IXUP Limited requested a trading halt on the ASX.
- The trading halt is pending an announcement related to a significant deployment of IXUP's technology by a project partner.
- The halt will remain until the earlier of normal trading on 28 August 2024 or the release of the announcement.
- The company is managing its continuous disclosure obligations.
- IXUP is a technology company focused on secure data analytics and has a suite of products for secure data collaboration.
- IXUP operates BetStop, the National Self Exclusion Register under contract with the Commonwealth Government of Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$746 |
Changes to Board of Directors and Management Team
|
26 Aug 2024 9:16AM |
$6.720 |
$2.320 |
fallen by
65.48%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$3 |
Appendix 4G
|
26 Aug 2024 9:16AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$3 |
2024 Corporate Governance Statement
|
26 Aug 2024 9:16AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$3 |
Appendix 4E and Annual Financial Report
|
26 Aug 2024 9:15AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
CT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Constellation Technologies Limited reported a 12.24% increase in revenue to $1,346,072 for the year ended 30 June 2024.
- The company recorded a net loss of $121,666, an improvement from the previous year's loss of $177,991.
- The Food Safety & Compliance (FSC) Module in the Callisto Solutions suite saw significant acceptance and the first major contract with Compass Group.
- The company's cash reserves decreased to $823,290 from $1,097,336 in the previous year.
- Total equity for the year ended 30 June 2024 stood at $872,218.
- Key risks identified include customer economic demand and reliance on senior key personnel.
- No dividends were paid or proposed during the financial year.
- No significant changes in the state of affairs occurred other than those disclosed in the Chairman's letter and CEO report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Vanadium Limited (AVL) ORDINARY FULLY PAID |
Materials |
$95 |
Call on Unquoted Partly Paid Shares
|
26 Aug 2024 9:15AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
| EVT Limited (EVT) ORDINARY FULLY PAID |
Communication Services |
$2,470 |
Appendix 4G and Corporate Governance Statement
|
26 Aug 2024 9:15AM |
$11.030 |
$15.200 |
risen by
37.81%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$341 |
Update - Notification of buy-back - AMH
|
26 Aug 2024 9:15AM |
$1.145 |
$1.080 |
fallen by
5.68%
|
|
| Foresta Group Holding Limited (FGH) ORDINARY FULLY PAID |
Materials |
$19 |
Disposal of Outdated Chemical Extraction Equipment
|
26 Aug 2024 9:14AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
FGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Essential Queensland Pty Ltd, a subsidiary of Foresta Group Holdings Limited, entered into an agreement to scrap outdated chemical extraction equipment in Rotorua, New Zealand.
- The equipment was purchased second-hand in May 2022 and dismantled by December 2022.
- The equipment was stored on site in Rotorua pending the development of the Company's flagship project in New Zealand.
- Thorough review and inspection revealed significant deterioration and safety risks, leading to the decision to scrap the equipment.
- The Board prioritized safety and determined that the outdated equipment posed significant safety and functional risks.
- The outdated equipment represented an unjustifiable financial liability, including insurance premiums and storage costs.
- The Company will receive NZD $208,580.10 (inclusive of GST) from the agreement.
- An impairment of approximately AUD $4,886,009 related to the equipment will be noted in the Company's annual report for the year ended 30 June 2024.
- The Company plans to purchase new, improved, and safe chemical extraction equipment for its New Zealand project, contingent on securing the necessary funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$67 |
ACW updated depression trial results and implications
|
26 Aug 2024 9:13AM |
$0.024 |
$0.021 |
fallen by
12.50%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen Medical announced positive results from the XanaCIDD phase 2a trial on depression.
- Xanamem treatment showed consistent benefits on symptoms of depression.
- A 10mg dose of Xanamem is effective in controlling brain cortisol and has anti-depressant activity.
- MADRS depression score improvement was significant in five of six subgroups.
- Patient Global Impression of Severity (PGI-S) data corroborated MADRS findings.
- Xanamem showed a 50% higher rate of remission of depression at Week 10.
- Therapeutic effects of Xanamem were durable, lasting four weeks post-treatment.
- Xanamem’s mechanism involves the inhibition of the 11ß-HSD1 enzyme, reducing brain cortisol levels.
- The XanaCIDD trial was a double-blind, placebo-controlled, six-week trial in 167 patients.
- Actinogen is exploring the path forward for Xanamem in treating Major Depressive Disorder (MDD).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$50 |
Completion of patient dosing in maiden TRP-8803 trial
|
26 Aug 2024 9:11AM |
$0.020 |
$0.036 |
risen by
80%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1b study of TRP-8803 completed with 11 participants.
- Participants given IV-infusion of psilocin over 150 minutes.
- Study aimed to refine dosing and infusion rates for TRP-8803.
- Achieved precise blood levels of psilocin with an acceptable pharmacokinetic profile.
- Completion marks an important milestone for Tryptamine Therapeutics Limited.
- Safety Review Council review of all data is now underway.
- Results to be used for future patent applications.
- Positive results will support future trials using TRP-8803.
- TRP-8803 trials de-risked through successful Phase 2a trials using TRP-8802.
- Phase 2a trials showed significant reductions in binge eating and fibromyalgia symptoms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$2 |
Final Director's Interest Notice (MH)
|
26 Aug 2024 9:11AM |
$0.036 |
$0.012 |
fallen by
66.67%
|
|
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$574 |
Dividend/Distribution - PCI
|
26 Aug 2024 9:11AM |
$1.115 |
$1.180 |
risen by
5.83%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$11 |
EU CRMA Strategic Project Application
|
26 Aug 2024 9:11AM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
| Frontier Energy Limited (FHE) ORDINARY FULLY PAID |
Utilities |
$118 |
Trading Halt
|
26 Aug 2024 9:11AM |
$0.455 |
$0.230 |
fallen by
49.45%
|
|
FHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Frontier Energy Limited (ASX: FHE) requested an immediate trading halt for its ordinary shares.
- The trading halt is related to a proposed capital raising by the company.
- The halt will last until the commencement of normal trading on 28 August 2024 or the release of an announcement.
- Frontier Energy Limited is developing the Waroona Renewable Energy Project in Western Australia.
- The project includes a 120MW solar farm and an 80MW 4-hour battery, with potential for over 1GW based on connection capacity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charter Hall Long Wale REIT (CLW) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,947 |
Update - Notification of buy-back - CLW
|
26 Aug 2024 9:10AM |
$3.790 |
$4.150 |
risen by
9.50%
|
|
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$376 |
Tax components of the distribution
|
26 Aug 2024 9:09AM |
$0.620 |
$0.700 |
risen by
12.90%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
